BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38365518)

  • 1. Contralateral Nodal Relapse in Well-lateralised Oral Cavity Cancers Treated Uniformly with Ipsilateral Surgery and Adjuvant Radiotherapy With or Without Concurrent Chemotherapy: a Retrospective Study.
    Swain M; Budrukkar A; Murthy V; Pai P; Kanoja A; Ghosh-Laskar S; Deshmukh A; Pantvaidya G; Kannan S; Patil VM; Naronha V; Prabhash K; Sinha S; Kumar A; Gupta T; Agarwal J
    Clin Oncol (R Coll Radiol); 2024 May; 36(5):278-286. PubMed ID: 38365518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
    González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL
    J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contralateral lymph node recurrence in breast cancer: Regional event rather than distant metastatic disease. A systematic review of the literature.
    Moossdorff M; Vugts G; Maaskant-Braat AJ; Strobbe LJ; Voogd AC; Smidt ML; Nieuwenhuijzen GA
    Eur J Surg Oncol; 2015 Sep; 41(9):1128-36. PubMed ID: 26108737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contralateral lymph node recurrence rate and its prognostic factors in stage IVA-B well-lateralized oral cavity cancer.
    Chien JC; Hu YC; Chang KC; Huang YH; Huang CY; Kang BH; Liu WS
    Auris Nasus Larynx; 2021 Oct; 48(5):991-998. PubMed ID: 33526320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and treatment of contralateral neck recurrence for unilateral oral squamous cell carcinoma: a retrospective study of 1482 cases.
    Feng Z; Niu LX; Yuan Y; Peng X; Guo CB
    Oral Oncol; 2014 Nov; 50(11):1081-8. PubMed ID: 25156479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with unilateral squamous cell carcinoma of the tongue and ipsilateral lymph node metastasis do not profit from bilateral neck dissection.
    Klingelhöffer C; Gründlinger A; Spanier G; Schreml S; Gottsauner M; Mueller S; Meier JK; Reichert TE; Ettl T
    Oral Maxillofac Surg; 2018 Jun; 22(2):185-192. PubMed ID: 29600319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple cervical lymph node involvement and extra-capsular extension predict for contralateral nodal recurrence after ipsilateral radiotherapy for squamous cell carcinoma of the tonsil.
    Lynch J; Lal P; Schick U; Nutting CM; Newbold K; Harrington K; Bhide S
    Oral Oncol; 2014 Sep; 50(9):901-6. PubMed ID: 25052236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of contralateral N0 neck in oral cavity squamous cell carcinoma.
    Koo BS; Lim YC; Lee JS; Choi EC
    Head Neck; 2006 Oct; 28(10):896-901. PubMed ID: 16721743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of regional lymph node failure of locally advanced hypopharyngeal squamous cell carcinoma after first-line treatment with surgery and/or intensity-modulated radiotherapy.
    Wang D; Yu S; Zhai L; Xu J; Li B
    BMC Cancer; 2020 Apr; 20(1):283. PubMed ID: 32252691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ipsilateral irradiation for oral and oropharyngeal carcinoma treated with primary surgery and postoperative radiotherapy.
    Vergeer MR; Doornaert PA; Jonkman A; Kaanders JH; van den Ende PL; de Jong MA; Leemans CR; Slotman BJ; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):682-8. PubMed ID: 20188492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT/3D-CRT.
    Guan X; Wang X; Liu Y; Hu C; Zhu G
    Oral Oncol; 2013 Jan; 49(1):60-5. PubMed ID: 22884302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of level IB nodal involvement in oropharynx cancer: Guidance for submandibular gland sparing irradiation.
    Lee NCJ; Kelly JR; Park HS; Yarbrough WG; Burtness BA; Husain ZA
    Pract Radiat Oncol; 2017; 7(5):e317-e321. PubMed ID: 28356201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of contralateral N0 neck in tonsillar squamous cell carcinoma.
    Lim YC; Lee SY; Lim JY; Shin HA; Lee JS; Koo BS; Kim SH; Choi EC
    Laryngoscope; 2005 Sep; 115(9):1672-5. PubMed ID: 16148715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy for T1/T2 oral cavity squamous cell carcinoma--a prospective case series.
    Pezier T; Nixon IJ; Gurney B; Schilling C; Hussain K; Lyons AJ; Oakley R; Simo R; Jeannon JP; McGurk M
    Ann Surg Oncol; 2012 Oct; 19(11):3528-33. PubMed ID: 22411202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node level ratio as a predictor of survival in oral cavity squamous cell carcinoma.
    Dermody SM; McMichael BM; Bellile E; Marchiano EJ; Chinn SB
    Oral Oncol; 2023 Nov; 146():106572. PubMed ID: 37742470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of High-Risk Subgroups of Patients With Oral Cavity Cancer in Need of Postoperative Adjuvant Radiotherapy or Chemo-Radiotherapy.
    Chen WC; Lai CH; Fang CC; Yang YH; Chen PC; Lee CP; Chen MF
    Medicine (Baltimore); 2016 May; 95(22):e3770. PubMed ID: 27258508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer.
    Ho AS; Kim S; Tighiouart M; Gudino C; Mita A; Scher KS; Laury A; Prasad R; Shiao SL; Van Eyk JE; Zumsteg ZS
    J Clin Oncol; 2017 Nov; 35(31):3601-3609. PubMed ID: 28880746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
    Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a New Outcome Prediction Model in Early-stage Squamous Cell Carcinoma of the Oral Cavity Based on Histopathologic Parameters With Multivariate Analysis: The Aditi-Nuzhat Lymph-node Prediction Score (ANLPS) System.
    Arora A; Husain N; Bansal A; Neyaz A; Jaiswal R; Jain K; Chaturvedi A; Anand N; Malhotra K; Shukla S
    Am J Surg Pathol; 2017 Jul; 41(7):950-960. PubMed ID: 28346327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological risk factors stratification in pN3b oral cavity squamous cell carcinoma: Focus on the number of positive nodes and extranodal extension.
    Liao CT; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Ng SH; Lin CH; Tsao CK; Kang CJ; Fang TJ; Huang SF; Chang KP; Yang LY; Yen TC
    Oral Oncol; 2018 Nov; 86():188-194. PubMed ID: 30409299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.